Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Stream

 

FREE BLOG Lack of legislation putting operators off in Saudi

At HBI 2018, talk about opportunities in MENA largely focused on Saudi Arabia, with Crown Prince Mohammed bin Salman's "Saudi Vision 2030" expected to privatise or outsource vast swathes of the country's healthcare system. So why haven't we seen much interest from private operators yet, and why is a flood of contracts not being signed?

Interview: Franz-Robert Klingan, Bain & Company

Healthcare Europa speaks to Franz-Robert Klingan, Munich-based partner at global consultants Bain & Company who runs its healthcare private equity practice for EMEA, to find out his three key messages from the last year and where he thinks the hotbeds of activity will be going forward.

Bidding war for Fortis pushes prospective price ever higher

The bidding war for India's second-largest hospital group continues to escalate despite the company board approving an offer of a capital injection last week from two wealthy family investor groups - and having previously supported a sale to Manipal - after shareholders made it clear they might prefer an outright takeover from other suitors.

New Mumbai hospital to focus on ambulatory care

Healthcare Nova speaks to Dr Sanjeev Kanoria, co-founder and chairman of UK-based care home specialists Advinia Health Care and deputy chairman of Anadi bank in Austria about his latest project, a  400-bed speciality hospital in Mumbai. 

Chinese health apps raise $1.6bn dollars – but are they what the doctor ordered?

Digital platforms in China are raising huge sums. In the last month, Tencent-backed WeDoctor raised $500m from investors in a private share sale that values the company at $5.5bn, while Ping An spinoff Good Doctor raised $1.1bn with a Hong Kong-exchange listed IPO. Healthcare Nova speaks to L.E.K.’s Shanghai-based managing director Stephen Sunderland to find out more about the digital health revolution.

Brazilian IPOs show an improving market – but were they a success?

Brazilian Healthcare providers Notre Dame Intermédica and Hapvida have both just gone public. Healthcare Nova speaks to a Brazil-based healthcare expert who shares his thoughts on whether the IPOs were successful, and what this means for the wider Brazilian healthcare market.

FREE BLOG Why big pharma will never move into health care services

A few  years ago, a senior manager from a large pharma company approached HBI and told us he had $500m to spend to build a healthcare service business - what should he do? Advisers tell of many similar calls. So why do they never come to anything? 

Opportunities in LATAM for those willing to think longer-term

Investors looking for medium- to long-term projects should look to Latam for opportunities according to a panel of healthcare experts at HBI 2018. A growing middle class across the continent, ageing populations and increasing stability in many countries, mean that it is ripe for investment.

Find Us